• Home
  • About Us
  • Contact US !
Incitasecurity
  • Home
  • Finance
  • Gadgets
  • Education
  • Latest Internet News
  • Technology
  • Social Media
  • Blogging
  • CrossFit
  • UpComing Car
No Result
View All Result
  • Home
  • Finance
  • Gadgets
  • Education
  • Latest Internet News
  • Technology
  • Social Media
  • Blogging
  • CrossFit
  • UpComing Car
No Result
View All Result
Incitasecurity
No Result
View All Result
Home Finance

KaloBios says Nasdaq to delist stock

anik by anik
January 15, 2016
in Finance
0
VIEWS
Share on FacebookShare on Twitter

KaloBios Pharmaceuticals Inc said on Wednesday that it had been notified by Nasdaq that its stock would be delisted using the exchange operator’s “discretionary” authority.

The Nasdaq cited the criminal indictment and arrest of the company’s former CEO Martin Shkreli; the arrest and indictment of Evan Greebel, KaloBios’ former outside counsel, and a civil complaint by the U.S. SEC against Shkreli and Greebel in its notification.

The drugmaker said on Monday that it had fired the controversial Shkreli on Dec. 17, the day he was arrested on charges of a securities fraud.

Martin Shkreli (C), chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs U.S. Federal Court after an arraignment following his being charged in a federal indictment filed in Brooklyn relating to his management of hedge fund MSMB Capital Management and biopharmaceutical company Retrophin Inc. in New York

Lucas Jackson | Reuters
Martin Shkreli (C), chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs U.S. Federal Court after an arraignment following his being charged in a federal indictment filed in Brooklyn relating to his management of hedge fund MSMB Capital Management and biopharmaceutical company Retrophin Inc. in New York

Shares of the company — which has not determined whether it will appeal the decision — have not traded since Thursday.

The deadline to request an appeal is Dec. 28, and if KaloBios decides to accept the ruling, the stock will be suspended from trading on Dec. 30.

Shkreli has been accused of running a Ponzi-like scheme at his former hedge fund MSMB Capital Management and Retrophin Inc, a company he headed before he took the helm of Turing Pharmaceuticals.

Shkreli stepped down as Turing CEO on
[“source -cncb”]

Tags: KaloBios says Nasdaq to delist stock
Previous Post

Apple releases iOS 9.2 to the public

Next Post

Buy these two ETFs for 2016: Traders

Next Post

Buy these two ETFs for 2016: Traders

Recent Post

  • Diane: Unleashing Strength and Stamina with CrossFit’s Intense WOD
  • Building Strength and Community: Unleashing the Power of CrossFit Sioux Falls
  • Exploring the CrossFit Monthly Cost: Breaking Down Membership Fees and Value
  • Comparing CrossFit Physiques to Traditional Gym Builds in Female Athletes: Exploring Strength, Stamina, and Aesthetics
  • Cracking the Code: Unveiling the CrossFit Chipper Workout
  • Revitalize Your Fitness Journey with Acid Bath CrossFit: Embrace the Intensity and Achieve Peak Performance
  • The Cost of CrossFit: Pricing and Membership Options Revealed
  • Mastering the Split Jerk: Unleashing Power and Precision in CrossFit
  • Fit Check-In: Energize Your Stay with Hotel CrossFit Workouts
  • Unleashing Strength and Determination: The Inspiring Journey of Danielle Brandon in CrossFit
Incitasecurity

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Navigate Site

  • Home
  • About Us
  • Contact US !

Follow Us

No Result
View All Result
  • Home
  • Finance
  • Gadgets
  • Education
  • Latest Internet News
  • Technology
  • Social Media
  • Blogging
  • CrossFit
  • UpComing Car

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.